Literature DB >> 3592744

Morphometric and ultrastructural analyses of melanocytes, nevus cells, and melanoma cells.

W Stolz, C Schmoeckel, F Ryckmanns, J Gross, O Braun-Falco.   

Abstract

Cytological atypia, revealed in the course of routine light microscopy, is considered a valuable indicator of malignancy in melanocytic lesions. A clear definition of the term cytological atypia, however, is lacking. Therefore, by morphometric analysis of ultrathin sections of 11 malignant melanomas (7 invasive, 3 in situ, and 1 lentigo maligna melanoma) and 10 compound nevi, we evaluated the discriminating power of the various facets of cytological atypia, i.e., nuclear area, area of the nucleolus, area of the total cell, and nuclear irregularity. In each case, at least 50 intraepidermal melanocytic cells were examined. The two-sided U-test showed significant differences between intraepidermal nevus and melanoma cells, with regard to the mean values (mean) and standard deviations (s) of the nuclear area (mean and s, p = 0.00011), area of the nucleolus (mean, p = 0.00043; s, p = 0.00011), and area of the total cell (mean, p = 0.00011; s, p = 0.00093). However, only the mean values and standard deviations of the nuclear area allowed a clear distinction in each individual case. The area of the nucleus can be estimated in the course of routine histology. We therefore think that the size and variation of the nuclear area should be considered in the histological differential diagnosis between malignant melanomas and benign nevi.

Entities:  

Mesh:

Year:  1987        PMID: 3592744     DOI: 10.1007/bf00413252

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  20 in total

1.  Ultrastructure of blood lymphocytes from chronic lymphocytic and lymphosarcoma cell leukemia.

Authors:  R Schrek
Journal:  J Natl Cancer Inst       Date:  1972-01       Impact factor: 13.506

2.  Comparative study on the ultrastructure of malignant melanoma and pigmented nevi.

Authors:  K Jukubowicz; J Dabrowski; W Biczysko; M Walski
Journal:  Acta Med Pol       Date:  1971

3.  The relation of prognosis to the nuclear diameter of breast cancer cells obtained by cytologic aspiration.

Authors:  A Zajdela; L S De LaRiva; N A Ghossein
Journal:  Acta Cytol       Date:  1979 Jan-Feb       Impact factor: 2.319

4.  Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.

Authors:  A B Ackerman; I Mihara
Journal:  Hum Pathol       Date:  1985-01       Impact factor: 3.466

5.  The histogenesis of malignant melanoma in relation to pre-existing pigmented lesions.

Authors:  V Crucioli; J Stilwell
Journal:  J Cutan Pathol       Date:  1982-12       Impact factor: 1.587

6.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.

Authors:  W H Clark; D E Elder; D Guerry; M N Epstein; M H Greene; M Van Horn
Journal:  Hum Pathol       Date:  1984-12       Impact factor: 3.466

7.  Evaluation of prognostic characteristics of stage I cutaneous malignant melanoma.

Authors:  G J Tan; J P Baak
Journal:  Anal Quant Cytol       Date:  1984-09

8.  How consistent are dermatopathologists in reading early malignant melanomas and lesions "precursor" to them? An international survey.

Authors:  C Schmoeckel
Journal:  Am J Dermatopathol       Date:  1984       Impact factor: 1.533

9.  Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.

Authors:  A R Rhodes; J W Melski; A J Sober; T J Harrist; M C Mihm; T B Fitzpatrick
Journal:  J Invest Dermatol       Date:  1983-05       Impact factor: 8.551

10.  The prognostic significance of morphometry in T1 bladder tumours.

Authors:  E C Ooms; E Essed; R W Veldhuizen; C L Alons; P Kurver; M E Boon
Journal:  Histopathology       Date:  1981-05       Impact factor: 5.087

View more
  1 in total

1.  Nuclear Transport Factor 2 (NTF2) suppresses WM983B metastatic melanoma by modifying cell migration, metastasis, and gene expression.

Authors:  Lidija D Vuković; Pan Chen; Sampada Mishra; Karen H White; Jason P Gigley; Daniel L Levy
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.